Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Other Accumulated Expenses (2020 - 2025)

IceCure Medical (ICCM) has disclosed Other Accumulated Expenses for 5 consecutive years, with $847000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Other Accumulated Expenses fell 7.93% to $847000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $847000.0, a 7.93% decrease, with the full-year FY2024 number at $847000.0, down 7.93% from a year prior.
  • Other Accumulated Expenses was $847000.0 for Q4 2024 at IceCure Medical, down from $920000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $3.5 million in Q4 2022 to a low of $847000.0 in Q4 2024.
  • A 5-year average of $2.2 million and a median of $2.9 million in 2020 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: rose 18.52% in 2022, then tumbled 73.37% in 2023.
  • IceCure Medical's Other Accumulated Expenses stood at $2.9 million in 2020, then grew by 2.1% to $2.9 million in 2021, then grew by 18.52% to $3.5 million in 2022, then tumbled by 73.37% to $920000.0 in 2023, then fell by 7.93% to $847000.0 in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Other Accumulated Expenses are $847000.0 (Q4 2024), $920000.0 (Q4 2023), and $3.5 million (Q4 2022).